Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adjuvant Global Health Technology Fund, L.P. Insider Profile
4 Followers
Adjuvant Global Health Technology Fund, L.P., Ten Percent Owner at AN2 Therapeutics, Inc., holds 2.37M shares in AN2 Therapeutics, Inc. (Ticker: ANTX). Most recently, Adjuvant Global Health Technology Fund, L.P. Sold $100,000 shares of AN2 Therapeutics, Inc. on Jan 18, 2024 for an estimated value of 1.97M.
Adjuvant Global Health Technology Fund, L.P. AN2 Therapeutics, Inc. (ANTX)Ten Percent Owner
AN2 Therapeutics, Inc. (ANTX)
Ten Percent Owner
Ranked #69,162 out of 97,197 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-17.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Adjuvant Global Health Technology Fund, L.P.'s holdings
Insider Roles
Ten Percent Owner
Roles that Adjuvant Global Health Technology Fund, L.P. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Adjuvant Global Health Technology Fund, L.P.
Adjuvant Global Health Technology Fund, L.P.'s Trading History
List of latest transactions for each holding click on a transaction to see Adjuvant Global Health Technology Fund, L.P.'s performance on stock
You May Also Like
Adjuvant Global Health Technology Fund, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Adjuvant Global Health Technology Fund, L.P.?
The percentage of profitable transactions made by Adjuvant Global Health Technology Fund, L.P. is 33%.
What is the average return per transaction made by Adjuvant Global Health Technology Fund, L.P.?
The average return per transaction made by Adjuvant Global Health Technology Fund, L.P. is -17.60%.
What stocks does Adjuvant Global Health Technology Fund, L.P. hold?
Adjuvant Global Health Technology Fund, L.P. holds: ANTX stocks.
What was Adjuvant Global Health Technology Fund, L.P.’s latest transaction?
Adjuvant Global Health Technology Fund, L.P. latest transaction was an Informative Sell of $1.97M.
What was Adjuvant Global Health Technology Fund, L.P.'s most profitable transaction?
Adjuvant Global Health Technology Fund, L.P.’s most profitable transaction was an Informative Sell of ANTX stock on January 18, 2024. The return on the trade was 6.20%.
What is Adjuvant Global Health Technology Fund, L.P.'s role in AN2 Therapeutics, Inc.?
Adjuvant Global Health Technology Fund, L.P.'s role in AN2 Therapeutics, Inc. is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.